Prudential PLC Regeneron Pharmaceuticals, Inc. Transaction History

Prudential PLC

$19.6 Billion
Q3 2024

A detailed history of Prudential PLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Prudential PLC holds 4,793 shares of REGN stock, worth $3.5 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

4,793

Previous 4,574 4.79%

Holding current value

$3.5 Million

Previous $4.81 Million 4.81%

% of portfolio

0.03%

Previous 0.03%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$1024.09 - $1201.76 $224,275 - $263,185	219 Added 4.79%	4,793 $5.04 Million
Q2 2024 Aug 06, 2024	BUY	$883.2 - $1071.19 $400,089 - $485,249	453 Added 10.99%	4,574 $4.81 Million
Q1 2024 May 14, 2024	SELL	$902.69 - $993.35 $571,402 - $628,790	-633 Reduced 13.32%	4,121 $3.97 Million
Q4 2023 Feb 13, 2024	SELL	$775.18 - $881.7 $12,402 - $14,107	-16 Reduced 0.34%	4,754 $4.18 Million
Q3 2023 Nov 09, 2023	SELL	$692.45 - $844.37 $1.96 Million - $2.39 Million	-2,831 Reduced 37.25%	4,770 $3.93 Million
Q2 2023 Aug 14, 2023	SELL	$700.03 - $830.35 $312,913 - $371,166	-447 Reduced 5.55%	7,601 $5.46 Million
Q1 2023 May 12, 2023	BUY	$680.49 - $826.97 $27,900 - $33,905	41 Added 0.51%	8,048 $6.61 Million
Q4 2022 Feb 08, 2023	BUY	$705.89 - $766.39 $1.94 Million - $2.11 Million	2,754 Added 52.43%	8,007 $5.78 Million
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $2.41 Million - $3.04 Million	-4,194 Reduced 44.4%	5,253 $3.62 Million
Q2 2022 Aug 12, 2022	BUY	$548.35 - $738.84 $2.11 Million - $2.84 Million	3,848 Added 68.73%	9,447 $5.58 Million
Q1 2022 May 13, 2022	BUY	$595.12 - $698.43 $1.98 Million - $2.32 Million	3,326 Added 146.33%	5,599 $3.91 Million
Q4 2021 Feb 11, 2022	SELL	$543.48 - $670.97 $161,413 - $199,278	-297 Reduced 11.56%	2,273 $1.44 Million
Q3 2021 Nov 10, 2021	SELL	$574.03 - $680.96 $2.59 Million - $3.07 Million	-4,508 Reduced 63.69%	2,570 $1.56 Million
Q1 2021 May 14, 2021	SELL	$446.73 - $548.2 $29,484 - $36,181	-66 Reduced 0.92%	7,078 $3.35 Million
Q4 2020 Feb 08, 2021	BUY	$478.3 - $607.98 $925,510 - $1.18 Million	1,935 Added 37.15%	7,144 $3.45 Million
Q3 2020 Oct 30, 2020	SELL	$544.75 - $658.21 $49,027 - $59,238	-90 Reduced 1.7%	5,209 $2.92 Million
Q2 2020 Jul 31, 2020	SELL	$493.32 - $643.92 $2.67 Million - $3.48 Million	-5,412 Reduced 50.53%	5,299 $3.31 Million
Q1 2020 May 01, 2020	BUY	$336.18 - $494.43 $1.16 Million - $1.7 Million	3,437 Added 47.25%	10,711 $5.23 Million
Q4 2019 Feb 13, 2020	SELL	$274.13 - $376.51 $18.2 Million - $25 Million	-66,389 Reduced 90.13%	7,274 $2.73 Million
Q3 2019 Nov 13, 2019	BUY	$273.46 - $318.39 $267,170 - $311,067	977 Added 1.34%	73,663 $20.4 Million
Q2 2019 Aug 14, 2019	BUY	$299.6 - $414.82 $190,545 - $263,825	636 Added 0.88%	72,686 $22.8 Million
Q1 2019 May 13, 2019	SELL	$372.08 - $439.57 $14.8 Million - $17.5 Million	-39,771 Reduced 35.57%	72,050 $29.6 Million
Q4 2018 Feb 13, 2019	SELL	$335.82 - $403.04 $46,343 - $55,619	-138 Reduced 0.12%	111,821 $41.8 Million
Q3 2018 Nov 14, 2018	SELL	$351.14 - $408.51 $89,891 - $104,578	-256 Reduced 0.23%	111,959 $45.2 Million
Q2 2018 Aug 14, 2018	BUY	$284.6 - $344.99 $1.47 Million - $1.78 Million	5,149 Added 4.81%	112,215 $38.7 Million
Q1 2018 May 15, 2018	BUY	$315.82 - $393.78 $8.87 Million - $11.1 Million	28,100 Added 35.58%	107,066 $36.9 Million
Q4 2017 Feb 14, 2018	BUY	$358.63 - $469.95 $10.1 Million - $13.2 Million	28,100 Added 55.24%	78,966 $29.7 Million
Q3 2017 Nov 14, 2017	BUY	$431.38 - $504.0 $3.07 Million - $3.59 Million	7,124 Added 16.29%	50,866 $22.7 Million
Q2 2017 Aug 14, 2017	BUY	N/A	43,742	43,742 $21.5 Million

Others Institutions Holding REGN

# of Institutions

1,532

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $78.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential PLC, based on Form 13F filings with the SEC.

News

Stay updated on Prudential PLC with notifications on news.

Account